Morphology, binding behavior and MR-properties of paramagnetic collagen-binding liposomes

Contrast Media and Molecular Imaging

Volumn 4, Issue 2, 2009, Pages 81-88

  Sanders, H M H F ^a   Stijkers, G J ^a   Mulder, W J M ^b   Huinink, H P ^a   Erich, S J F ^a   Adan, O C G ^a   Sommerdijk, N A J M ^a   Merkx, M ^a   Nicolay, K ^a  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

CNA35; Collagen; Contrast enhanced MRI; Cryo TEM; Molecular imaging; Paramagnetic liposomes

Indexed keywords

COLLAGEN; CONTRAST MEDIUM; LIPOSOMAL COLLAGEN BINDING ADHESION PROTEIN 35; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONJUGATION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANIMALS; COLLAGEN; CONTRAST MEDIA; CRYOELECTRON MICROSCOPY; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MICROSCOPY, ELECTRON, TRANSMISSION; RATS;

EID: 65649136228     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.266     Document Type: Article

References (34)

1. Rekhter MD. Collagen synthesis in atherosclerosis: too much and not enough. Cardiovasc. Res. 1999; 41(2): 376-384.
2. Libby P. Inflammation and atherosclerosis. Circulation 2002; 105(9): 1135-1143.
3. Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 2003; 108(11): 1395-1403.
4. Cleutjens JP. The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc. Res. 1999; 44(2): 232-241.
5. Myllyharju J. Collagens and collagen-related diseases. Ann. Med. 2001; 33(1): 7-21.
6. Plenz GA. What are appropriate controls for cardiac interleukin-6 expression in heart failure? Circulation 2003; 108(17): e129-130 author reply e 129-130.
7. Rodriguez-Feo JA. Modulation of collagen turnover in cardiovascular disease. Curr. Pharm. Des. 2005; 11(19): 2501-2514.
8. Katsuda S. Atherosclerosis and extracellular matrix. J. Atheroscler. Thromb. 2003; 10(5): 267-274.
9. Megens RT. Imaging collagen in intact viable healthy and atherosclerotic arteries using fluorescently labeled CNA35 and two-photon laser scanning microscopy. Mol. Imag. 2007; 6(4): 247-260.
10. Barnes MJ. Collagens and atherosclerosis. Exp. Gerontol. 1999; 34(4): 513-525.
11. Blankesteijn WM. Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice. Acta Physiol. Scand. 2001; 173(1): 75-82.
12. Jugdutt BI. Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models. Circulation 1996; 94(1): 94-101.
13. Caravan P. Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. Angew. Chem. Int. Edn Engl. 2007; 46(43): 8171-8173.
14. Navon G. Multiquantum filters and order in tissues. NMR Biomed. 2001; 14(2): 112-132.
15. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem. Soc. Rev. 2006; 35(6): 512-523.
16. Mulder WJ. A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjug. Chem. 2004; 15(4): 799-806.
17. Storrs RW. Paramagnetic polymerized liposomes as new recirculating MR contrast agents. J. Magn. Reson. Imag. 1995; 5(6): 719-724.
18. Maruyama K. Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. Biochim. Biophys. Acta 1993; 1149(2): 209-216.
19. Matsumura Y. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986; 46 (12 Pt 1): 6387-6392.
20. Mulder WJ. Liposome-enhanced MRI of neointimal lesions in the ApoE-KO mouse. Magn. Reson. Med. 2006; 55(5): 1170-1174.
21. Lobatto ME. Novel nanomedicine for anti-inflammatory therapy of atherosclerosis monitored by multimodalitly imaging. Proc. Int. Soc. Magn. Reson. Med. 2008.
22. Torchilin VP. Poly(ethylene glycol)-coated anti-cardiac myosin immunoliposomes: factors influencing targeted accumulation in the infarcted myocardium. Biochim. Biophys. Acta 1996; 1279(1): 75-83.
23. Torchilin VP. Targeting of liposomes within cardiovascular system. J. Liposome Res. 1997; 7(4): 433-454.
24. Gabizon A. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J. Natl Cancer Inst. 1989; 81(19): 1484-1488.
25. Zhao M. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat. Med. 2001; 7(11): 1241-1244.
26. Sosnovik DE. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn. Reson. Med. 2005; 54(3): 718-724.
27. Hiller KH. Assessment of cardiovascular apoptosis in the isolated rat heart by magnetic resonance molecular imaging. Mol. Imag. 2006; 5(2): 115-121.
28. Zong YA. 'Collagen Hug' model for Staphylococcus aureus CNA binding to collagen. Embo J. 2005; 24(24): 4224-4236.
29. Mingels AM. Mapping preferred sites for fluorescent labeling by combining fluorescence and MS analysis of tryptic CNA35 protein digests. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008; 863(2): 293-297.
30. Krahn KN. Fluorescently labeled collagen binding proteins allow specific visualization of collagen in tissues and live cell culture. Anal. Biochem. 2006; 350(2): 177-185.
31. Boerboom RA. High resolution imaging of collagen organisation and synthesis using a versatile collagen specific probe. J. Struct. Biol. 2007; 159(3): 392-399.
32. Huinink HP. High-resolution NMR imaging of paramagnetic liposomes targeted to a functionalized surface. Magn. Reson. Med. 2008; 59(6): 1282-1286.
33. Reulen SW. Protein-liposome conjugates using cysteine-lipids and native chemical ligation. Bioconjug. Chem. 2007; 18(2): 590-596.
34. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248-254.